The 20 Best Mitral Valve Regurgitation Doctors Near Me in Ann Arbor, MI

Dr. Gorav Ailawadi joined the University of Michigan as the Chair of Cardiac Surgery in September of 2020. Previously, he served as the Chief of Cardiac Surgery, Co-Director of the Cardiac Valve Center, and Director of the Medical Device Innovation Center at the University of Virginia.Dr. Ailawadi was raised in Maryland and New Jersey. He attended an accelerated honors program in medical education at Northwestern University where he received the awards for best overall student and top surgical student. Additionally, he was elected to the Alpha Omega Alpha Honor Society. While completing a surgery residency at the University of Michigan, Dr. Ailawadi spent two research years investigating and understanding the development of aortic aneurysms. His work was recognized by the NIH/Lifeline Association and was chosen as the top research project in 2003. While at Michigan, he received the Top Resident and Young Investigator Awards. He then completed his training and joined the faculty at the University of Virginia in thoracic and cardiovascular surgery.Dr. Ailawadi has internationally-recognized expertise in mitral and aortic valve disease with vast experience in minimally invasive cardiac surgery, and percutaneous/transcatheter valve therapies having performed over 600 minimally invasive procedures and roughly 3000 heart operations. He has been invited to national and international conferences to share his expertise with novel minimally invasive approaches, valve disease, reoperative and AF surgery.At Virginia, Dr. Ailawadi was the first surgeon in the U.S. to perform hybrid AF ablation, the first U.S. Surgeon to perform the MitraClip procedure, and the world’s first transcaval TEVAR procedure. He has been the principal investigator for a novel left atrial appendage clip to prevent strokes in patients with atrial fibrillation. Dr. Ailawadi served one of five core principal investigators leading the CTSN linked research consortium (NIH) developing new trials in cardiac surgery. Currently, Dr. Ailawadi is on the executive steering committee for numerous transcatheter and surgical trials in valvular disease. Dr. Ailawadi is the surgical national principal investigator for the Summit Trial investigating TENDYNE, a transcatheter mitral valve replacement without stopping the heart. In 2019, Dr. Ailawadi completed his MBA from the Darden School of Business.Dr. Ailawadi has been funded by the NIH, AHA, among other grants. His research lab studies novel mechanisms and new treatments for aortic aneurysms. He has published over 350 peer-reviewed manuscripts in journals, including the New England Journal of Medicine, Circulation, and JACC. Dr. Ailawadi is member of the American Association for Thoracic Surgeons, the American Surgical Association, and the Cardiac Surgery Biology Club. In his leisure time, Dr. Ailawadi enjoys exercise, sports, and spending time with his wife, Aarti, and their three children. Dr. Ailawadi is rated as an Elite provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Thoracic Aortic Aneurysm, Tricuspid Regurgitation, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery. Dr. Ailawadi is board certified in Thoracic & Cardiac Surgery and Surgery.

Dr. Steven F. Bolling's expertise in mitral valve repair continues to result in a large volume of referrals for mitral valve reconstruction. His innovative approach to mitral valve repair in patients with end-stage left ventricular failure and outstanding ability to repair even the most challenging mitral valve abnormalities have received wide spread international acclaim.Bibliography 283. Bolling SF. First TMVR Enters U.S. Market as a Therapy and a Gateway. J Am Coll Cardiol. 2017 Nov 7;70(19):2328-2329. Doi: 10.1016/j.jacc.2017.09.1081. No abstract available. PMID:29096802.284. Rogers JH, Boyd WD, Smith TWR, Ebner AA, Bolling SF. Combined MitraClip Edge to Edge Repair with Millipede IRIS Mitral Annuloplasty. JACC Cardiovasc Interv. 2018 Feb 12;11(3):323-324. Doi: 10.1016/j.jcin.2017.11.007. No abstract available. PMID: 29413250.292. LaPar DJ, Likosky DS, Zhang M, Theurer P, Fonner CE, Kern JA, Bolling SF, Drake DH, Speir AM, Rich JB, Kron IL, Prager RL, Ailawadi G; Investigators for the Virginia Cardiac Surgery Quality Initiative (VCSQI) and the Michigan Society of Thoracic and Cardiovascular Surgeons (MSTCVS). Development of a Risk Prediction Model and Clinical Risk Score for Isolated Tricuspid Valve Surgery. Ann Thorac Surg. 2018 Feb 1. [Epub ahead of print] PMID: 29410187.293. Mack MJ; Abraham WT; Lindenfeld J; Bolling SF; et al. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and Rationale of the COAPT Trial. Am Heart J. 2018 Nov;205: 1-11. PMID: 30134187295. Rankin JS, Grau-Sepulveda M, Shahian DM, Gillinov AM, Suri R, Gammie JS, Bolling SF, McCarthy PM, Thourani VH, Ad N, O'Brien SM, Jacobs JP, Badhwar V. The Impact of Mitral Disease Etiology on Operative Mortality Following Mitral Valve Operations. Ann Thorac Surg. 2018 May 16. pii: S0003-4975(18)30683-0. doi: 10.1016/j.athoracsur.2018.04.053. [Epub ahead of print] PMID: 29777670.296. Gammie JS, Chikwe J, Badhwar V, Thibault DP, et al. Isolated Mitral Valve Surgery: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis. Ann Thorac Surg. 2018 Sept: 106(3):716-727. PMID: 30032907.299. Taramasso M, Gavazzoni M, Pozzoli A, Dreyfus GD, Bolling SF, et al. Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease. JACC Cardiovasc Imaging. 2019 Apr;12(4):605-621. PMID: 30947904.300. Hobbs RD, Assi A, Bolling SF, Patel HJ, Deeb GM, Romano MA, Haft JW, et al. Long-Term Survival and Echocardiographic Findings After Surgical Ventricular Restoration. Ann Thorac Surg. 2019 Jun;107(6):1754-1760. PMID: 30586580. Dr. Bolling is rated as an Elite provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Mitral Stenosis, Tricuspid Regurgitation, Pacemaker Implantation, and Patent Foramen Ovale Repair. Dr. Bolling is board certified in Thoracic & Cardiac Surgery.

Matthew A. Romano, M.D., is an Associate Professor of Cardiac Surgery and the Director of the multidisciplinary Mitral Valve Clinic. He joined the faculty in 2009 following the completion of thoracic surgery and surgical critical care residencies at the University of Michigan. He received additional advanced training in the surgical treatment of complex valvular heart disease and heart transplantation. His clinical interests and expertise include mitral and tricuspid valve repair, minimally invasive valve surgery, percutaneous and catheter based mitral and tricuspid valve repair and replacement, and treatment of atrial fibrillation. He was recently awarded the American Heart Association/Mitral Foundation Mitral Valve Reference Surgeon distinction for his high rate of mitral valve repair and excellent outcomes. He has established a minimally invasive surgical program for isolated treatment of atrial fibrillation. His research is focused on mitral valve disease as well as atrial fibrillation and heart failure. Dr. Romano is rated as an Elite provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Mitral Stenosis, Endocarditis, Heart Valve Repair, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Romano is board certified in Thoracic & Cardiac Surgery and Surgical Critical Care.

Stanley J. Chetcuti, M.D., is a Clinical Professor of Internal Medicine and the Eric J. Topol Collegiate Professor of Cardiovascular Medicine who serves as Director of the Cardiac Catheterization Laboratory and the Interventional Cardiology Fellowship Program. His research focuses on percutaneous circulatory support systems, novel treatment for acute coronary syndromes, and percutaneous management of patients with structural heart disease. Dr. Chetcuti is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Aortic Regurgitation, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Chetcuti is board certified in Cardiovascular Disease and Interventional Cardiology.

Dr. Daniel S. Menees is an Assistant Professor in the Cardiovascular Medicine Division at the University of Michigan. He currently serves as the Program Director of the Interventional Cardiology Fellowship Program. After completing his medical school training at Rush University in Chicago, Illinois, he did his residency in Internal Medicine followed by fellowship in both Cardiovascular Disease and Interventional Cardiology at the University of Michigan. In addition to fellow education, his interests include complex and high risk percutaneous coronary interventions (CHIP) and he directs the Chronic Total Occlusion (CTO) program. Additionally, he is actively involved in the TAVR program and has both clinical and research interest in percutaneous mitral valve therapies. Dr. Menees is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Coronary Heart Disease, Angina, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Menees is board certified in Cardiovascular Disease and Interventional Cardiology.

Kenneth Tobin is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Tobin is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Mitral Valve Regurgitation, Mitral Stenosis, and Bicuspid Aortic Valve. Dr. Tobin is board certified in Cardiology.

Dr. Megan Shetty Joseph is a cardiologist and echocardiographer in the Division of Cardiovascular Medicine at the University of Michigan. She sees patients at the Frankel Cardiovascular Center and is a member of the multidisciplinary structural heart team.She received her bachelor’s degree from the University of Pennsylvania and medical degree from Baylor College of Medicine. She completed her Internal Medicine residency training at the University of Michigan and subsequently served as Chief Medical Resident. She completed fellowship training in Cardiovascular Medicine at the University of Michigan where she served as Chief Fellow.Dr. Joseph’s interests include valvular heart disease, the use of echocardiography to guide procedures for structural heart disease, ways to improve diversity in the field of cardiology,and medical education. Dr. Joseph is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Mitral Valve Regurgitation, Aortic Valve Stenosis, Mitral Stenosis, Familial Hypertrophic Cardiomyopathy, and Cardiac Ablation. Dr. Joseph is board certified in Internal Medicine and Cardiovascular Disease.

Adam Stein is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Stein is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Familial Ventricular Tachycardia, Inappropriate Sinus Tachycardia (IST), Arrhythmias, Cardiac Ablation, and Pacemaker Implantation. Dr. Stein is board certified in Cardiovascular Disease.

Sara Saberi is an Assistant Professor in the Division of Cardiovascular Medicine and a member of the Inherited Cardiomyopathy Program at the Frankel Cardiovascular Center. She received her bachelor's degree from Northwestern University in Evanston, IL and her medical degree from Wayne State University in Detroit, MI. She obtained her residency training in Internal Medicine and fellowship training in Cardiovascular Medicine at University of Michigan. She joined the faculty at Michigan in 2010. Dr. Saberi’s clinical work is focused on providing comprehensive care to patients with genetic cardiomyopathies and their families. Her research work focuses on clinical research aimed at learning more about inherited cardiomyopathies and development of new treatments to prevent or delay onset or progression of disease. One of her areas of focus is determining the impact of exercise training on outcomes, disease features, and quality of life in patients with hypertrophic cardiomyopathy and establishing evidence-based guidelines to inform recommendations for athletes with cardiomyopathies. Dr. Saberi is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. She is also highly rated in 32 other conditions, according to our data. Her clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Cardiac Ablation, and Pacemaker Implantation. Dr. Saberi is board certified in Cardiovascular Disease.

Theodore Kolias is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Kolias is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Bicuspid Aortic Valve, Aortic Valve Stenosis, Mitral Valve Regurgitation, Cardiac Ablation, and Atherectomy. Dr. Kolias is board certified in Cardiovascular Disease.

Dr. Bhave is a general cardiologist and echocardiographer with an interest in clinical informatics. A graduate of Harvard Medical School, she completed her internal medicine residency at Massachusetts General Hospital. At the University of Chicago, she completed fellowships in cardiovascular medicine and advanced cardiac imaging, including three-dimensional echocardiography and cardiovascular magnetic resonance. She joined the faculty at U-M Health in 2013 and serves as the Associate Chief Medical Information Officer for Cardiology. In her work with the Michigan Medicine kidney and liver transplant programs, she sees patients both pre- and post-transplant. She is active in several professional societies, including the American College of Cardiology and the American Society of Echocardiography. She is passionate about providing high-quality, high-value care. Dr. Bhave is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Regurgitation. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Cardiomyopathy, Aortic Valve Stenosis, Thoracic Aortic Aneurysm, Cardiac Ablation, and Angioplasty.

Sarah Kohnstamm is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Kohnstamm is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Regurgitation. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Aortic Valve Stenosis, Heart Failure with Preserved Ejection Fraction (HFpEF), Constrictive Pericarditis, Heart Failure, and Pacemaker Implantation.

Fred Morady is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Morady is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 84 other conditions, according to our data. His clinical expertise encompasses Arrhythmias, Ectopic Heartbeat, Atrial Fibrillation, Paroxysmal Supraventricular Tachycardia (PSVT), and Cardiac Ablation.

Francis D. Pagani, M.D., Ph.D., is the Otto Gago MD Endowed Professor in Cardiac Surgery. Dr. Pagani’s clinical focus includes surgical therapies for advanced heart failure including heart transplantation and mechanical circulatory support, complex re-operative surgery for valvular heart disease, and surgery for coronary artery disease. Dr. Pagani also serves as the surgical lead for the multidisciplinary Hypertrophic Cardiomyopathy program and has an active practice in surgical treatments (myectomies) for this disorder. Dr. Pagani also serves as the surgical lead for The Center for Circulatory Support (VAD Program). Dr. Pagani’s has an active research program supported, in part, by the National Heart, Lung, and Blood Institute (NHLBI) and Agency for Healthcare Research and Quality (AHRQ). His research focuses on the bioengineering development and clinical testing of mechanical circulatory support devices in the treatment of end-stage heart disease, clinical health outcomes research, and use of stem cell transplantation for myocardial regeneration. Dr. Pagani is rated as a Distinguished provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Mitral Valve Regurgitation, Restrictive Cardiomyopathy (RCM), Heart Transplant, and Heart Bypass Surgery. Dr. Pagani is board certified in Thoracic & Cardiac Surgery.

Victor M. Moles is a Clinical Assistant Professor in the Division of Cardiovascular Medicine. He is part of the Pulmonary Hypertension Program. He received his medical degree from Universidad del Salvador School of Medicine in Buenos Aires, Argentina. He completed his Internal Medicine Internship and Residency training at Georgetown University Hospital, Washington, D.C. where he also served as a Chief Medical Resident. He received his training in Cardiovascular Medicine with focus on Pulmonary Hypertension at the University of Michigan Cardiovascular Center. Dr. Moles is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Pulmonary Embolism, Pulmonary Edema, and Angioplasty. Dr. Moles is board certified in Cardiovascular Disease.

Dr. Hitinder S. Gurm is an interventional cardiologist and is a Professor of Internal Medicine . He is currently serving as the interim Chief Medical Officer of the University of Michigan Health System. Dr. Gurm is a graduate of Christian Medical College, Ludhiana, India. He did his residency in Internal medicine followed by a fellowship in Cardiology and Interventional Cardiology at the Cleveland Clinic Foundation. His research interests include carotid interventions, contrast-induced nephropathy, quality improvement and outcomes assessment, and development of novel devices for endovascular interventions. He has published more than 250 original articles and book chapters and has been named as an inventor on 4 patents. He is the recipient of the Michigan Health & Hospital Association’s Patient Safety & Quality Leadership Award for 2016 and has been elected to the American Society for Clinical Investigation (ASCI). Dr. Gurm was selected as one of 50 experts leading the field of patient safety in 2018 by Becker Hospital Review. Dr. Gurm is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Heart Attack, Coronary Heart Disease, Atherosclerosis, Lithotripsy, and Percutaneous Coronary Intervention (PCI). Dr. Gurm is board certified in Cardiovascular Disease and Interventional Cardiology.

William Armstrong is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Armstrong is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Aortic Valve Stenosis, Cardiac Ablation, and Pacemaker Implantation. Dr. Armstrong is board certified in Internal Medicine and Cardiovascular Disease.

Sascha Goonewardena is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Goonewardena is rated as an Advanced provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Inappropriate Sinus Tachycardia (IST), Familial Ventricular Tachycardia, Arrhythmias, and Mitral Valve Regurgitation. Dr. Goonewardena is board certified in Cardiovascular Disease.

Kim Eagle is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Eagle is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Aortic Dissection, Marfan Syndrome, Thoracic Aortic Aneurysm, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI). Dr. Eagle is board certified in Internal Medicine and Cardiovascular Disease.

Acute ischemic syndromes and coronary revascularization. Dr. Bates is rated as an Experienced provider by MediFind in the treatment of Mitral Valve Regurgitation. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Heart Attack, Angina, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.